Original Article

Journal of Cerebral Blood Flow & Metabolism (2006) 26, 449–455. doi:10.1038/sj.jcbfm.9600204; published online 10 August 2005

Cerebral vascular effects of angiotensin II: new insights from genetic models

This work was supported by National Institutes of Health grants HL-38901, HL-62984, NS-24621, HL-61446 and HL-76421 and AHA grant 0575092N.

Frank M Faraci1,2, Kathryn G Lamping1,2, Mary L Modrick1, Michael J Ryan1, Curt D Sigmund1,3 and Sean P Didion1

  1. 1Department of Internal Medicine, Cardiovascular Center, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA
  2. 2Department of Pharmacology, Cardiovascular Center, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA
  3. 3Department of Physiology, Cardiovascular Center, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA

Correspondence: Dr FM Faraci, Department of Internal Medicine, E318-2-GH, University of Iowa, Carver College of Medicine, Iowa City, IA 52242-1081, USA. E-mail: frank-faraci@uiowa.edu

Received 12 May 2005; Revised 28 June 2005; Accepted 6 July 2005; Published online 10 August 2005.

Top

Abstract

Very little is known regarding the mechanisms of action of angiotensin II (Ang II) or the consequences of Ang II-dependent hypertension in the cerebral circulation. We tested the hypothesis that Ang II produces constriction of cerebral arteries that is mediated by activation of AT1A receptors and Rho-kinase. Basilar arteries (baseline diameter approx130 mum) from mice were isolated, cannulated and pressurized to measure the vessel diameter. Angiotensin II was a potent constrictor in arteries from male, but not female, mice. Vasoconstriction in response to Ang II was prevented by an inhibitor of Rho-kinase (Y-27632) in control mice, and was reduced by approx85% in mice deficient in expression of AT1A receptors. We also examined the chronic effects of Ang II using a model of Ang II-dependent hypertension, mice which overexpress human renin (R+) and angiotensinogen (A+). Responses to the endothelium-dependent agonist acetylcholine were markedly impaired in R+A+ mice (P<0.01) compared with controls, but were restored to normal by a superoxide scavenger (PEG-SOD). A-23187 (another endothelium-dependent agonist) produced vasodilation in control mice, but no response or vasoconstriction in R+A+ mice. In contrast, dilation of the basilar artery in response to a NO donor (NONOate) was similar in R+A+ mice and controls. Thus, Ang II produces potent constriction of cerebral arteries via activation of AT1A receptors and Rho-kinase. There are marked gender differences in cerebral vascular responses to Ang II. Endothelial function is greatly impaired in a genetic model of Ang II-dependent hypertension via a mechanism that involves superoxide.

Keywords:

acetylcholine, basilar artery, endothelium, genetically altered mice

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

Extra navigation

.

naturejobs

ADVERTISEMENT